Joining the 5th International Neurosurgery & Neurological Surgeons Conference

We are delighted to announce that Dr. Anantha Kumar Murugavel will be a distinguished speaker at the upcoming , a ‑accredited event scheduled for January 14–16, 2026, at , , . Today's the final day for — a timely call for all neurosurgeons, , , and allied professionals worldwide.

As a speaker, Dr. Murugavel will deliver a presentation entitled:
“Role of Middle Meningeal Artery Embolisation in the Treatment of Residual/Recurrent Chronic Subdural Hematoma: A Randomised Controlled Trial.”

This presents an exciting opportunity to delve into cutting‑edge neurosurgical research on minimally invasive endovascular management of chronic subdural hematoma (cSDH) — a topic of increasing relevance to neuro‑trauma care, elderly neurosurgical populations, and neuro‑interventional practice.

Why This Topic Matters: Middle Meningeal Artery Embolisation for Chronic Subdural Hematoma

Chronic subdural hematoma (cSDH) remains a frequent and challenging condition in neurosurgery, particularly among elderly patients, or those with comorbidities, anticoagulation, or other risk factors. Traditionally, cSDH is managed surgically — via burr‑hole drainage or craniotomy — but such approaches often carry a substantial risk of recurrence, perioperative morbidity, or prolonged recovery.

In recent years, middle meningeal artery (MMA) embolization has emerged as a promising, minimally invasive alternative — either as a primary therapy or as an adjunct to surgery. The rationale is grounded in evolving understanding of cSDH pathophysiology: rather than a passive static blood collection, many chronic subdural hematomas are maintained by a vascularized, neomembrane that continues to leak blood via fragile microvessels supplied largely by branches of the MMA.

By occluding the arterial supply — via endovascular selective catheterization and infusion of embolic agents — MMA embolization disrupts the pathological cycle of micro‑hemorrhage into the subdural space, promoting hematoma resorption and reducing recurrence risk.

Multiple case series and observational studies have documented favorable outcomes: significant reduction in hematoma size, symptomatic improvement, and avoidance of repeat surgery in a large proportion of patients. For example, in a series of 60 cSDH cases treated with MMA embolization, 91.1% remained stable or reduced in size without need for further surgery.

Further, a multicenter series of 154 embolizations demonstrated a median hematoma thickness reduction from 14 mm to around 4 mm over follow‑up, with a majority showing > 50% reduction on imaging and a low rate of additional surgical intervention.

A recent meta-analysis comparing MMA embolization to conventional surgery concluded that embolization significantly reduces treatment failure and surgical rescue rates, improves rates of complete hematoma resolution, without increasing complications or mortality.

Given this growing body of evidence, the topic of your planned presentation — a randomised controlled trial on MMA embolization for residual/recurrent cSDH — is timely and likely to generate considerable interest among neuro‑trauma specialists, endovascular neurosurgeons, and the broader neurosurgical community.

About Dr. Anantha Kumar Murugavel — Speaker & Researcher

While details about Dr. Murugavel’s full background beyond the conference announcement are limited in the public domain, his selection as a speaker at an international, CME‑accredited neurosurgery conference underscores his standing in the field. Delivering a talk on MMA embolization for cSDH indicates a focus on advanced neuro‑interventional procedures and evidence‑based neurosurgical care.

By contributing a randomized controlled trial (RCT), Dr. Murugavel aims to provide high‑level evidence — potentially influencing practice guidelines for management of recurrent/residual cSDH globally. The inclusion of such research in the conference agenda reflects both the importance of minimally invasive techniques in modern neurosurgery, and the growing interest in shifting paradigms from traditional open surgery to endovascular approaches.

What to Expect at the 5th International Neurosurgery and Neurological Surgeons Conference (INNSC‑2026)

The 5th INNSC is shaping up to be a comprehensive global gathering of neurosurgeons, neurointerventionists, neurologists, neuroradiologists, residents, fellows, and allied professionals. Here’s what the event promises — and why you should register (especially while early‑bird registration is still open):

• Broad Scientific Program & CME/CPD Accreditation

Attendees will have access to 80+ scientific sessions, covering a wide spectrum of neurosurgical and neurological subspecialties — from neuro‑trauma, cerebrovascular/endovascular, spine, neuro‑oncology, functional neurosurgery to neurocritical care, neuro‑imaging, and more. The CME/CPD accreditation ensures that participation contributes to continuing professional development and recognition internationally.

• Networking & Collaboration Opportunities

The conference offers unparalleled opportunities to connect with renowned neurosurgeons, interventional neuroradiologists, researchers, and industry experts. As a speaker, you — and other attendees — gain visibility, open doors for collaborations, share insights, and build professional relationships across global neuro‑surgical communities.

• Exposure for Your Research & Clinical Work

In addition to oral presentation slots and Q&A, registered speakers receive a conference proceeding kit, professional photography and videography, and their profile with talk title and institution will be featured on the conference website — valuable for academic CVs and global visibility.

• Abstract Submission & Publication Potential

For those who may wish to contribute further, many conferences like INNSC offer abstract submission opportunities — not only for oral presentations but also posters or e‑poster sessions. While your talk already covers your RCT, colleagues might submit additional abstracts on related topics (e.g., neuro‑imaging, neuro‑intervention, case series, surgical innovations). The process typically involves writing a concise abstract (summary of aim, methods, results, conclusion), following the conference’s formatting guidelines, and submitting it before the specified deadline.

Abstracts accepted are often included in conference proceedings or special issue supplements — providing wider dissemination and potential peer recognition.

Submit Your Abstracts Here:https://neurosurgery.utilitarianconferences.com/submit-abstract

• Exhibitors & Industry Engagement

Apart from scientific sessions, INNSC‑2026 is likely to host exhibitors — companies from neurosurgical instruments, neuro‑imaging, endovascular devices, neuronavigation, implants, neuro‑critical care equipment, neuro‑rehabilitation, and allied medical technology sectors. This provides a chance to interact with vendors, learn about latest technologies, compare devices, and possibly establish ties for future research, clinical use, or institutional procurement.

For attendees — especially from institutions considering upgrades or establishing neuro‑intervention programs — exhibitor halls offer insight into cutting‑edge tools, materials, and services.

• Professional Development & Career Advancement

For early‑career neurosurgeons, trainees, fellows — and even experienced practitioners — attending INNSC‑2026 offers continuing medical education (CME/CPD) credits, exposure to latest evidence and techniques, platform to present research, and opportunities to grow their academic and clinical networks. For speakers like Dr. Murugavel, it presents a moment to showcase impactful research on MMA embolization for cSDH, potentially influencing future standards of care.

The Call to Action: Register, Submit, Engage

With today being the Early Bird Registration Deadline, this is an opportune moment to secure your spot at INNSC‑2026 — whether you plan to attend sessions, present research, or meet industry experts. Early‑bird registration typically offers discounted rates, priority seat allocation, and ensures availability before full capacity is reached.

If you are a neurosurgical resident, fellow, or practitioner with ongoing research — consider submitting an abstract. Even short case series, retrospective analyses, neuro‑imaging studies, or reports on surgical / endovascular innovations can fit well in such conferences. Participating in exhibitor events can also open dialogues for institutional collaborations or clinical procurement if you're associated with a hospital or neuro‑center.

For speakers like Dr. Murugavel, preparing a high‑quality presentation — with 25–30 slides in widescreen format as per conference guidelines — and submitting slides ahead of time will ensure smooth delivery, technical readiness, and compliance with speaker requirements.

Kindly Register Here : https://neurosurgery.utilitarianconferences.com/registration

Significance of the Topic in Contemporary Neurosurgery — A Broader View

Why is MMA embolization important enough to be highlighted at an international neurosurgery conference? The answer lies in several converging trends:

Demographic change: Aging populations worldwide mean more elderly patients with cSDH — often with comorbidities, anticoagulation, or frailty — for whom conventional surgery may carry higher risk. Minimally invasive alternatives like MMA embolization are safer, better tolerated, with lower morbidity.
Evolving pathophysiology understanding: Research increasingly supports that chronic subdural hematomas are dynamic, vascularized lesions maintained by fragile neovasculature, rather than inert chronic bleed. Targeting the vascular supply addresses the root pathological mechanism, not just the symptom (blood collection).
Reduction of recurrence and re‑operation: Traditional surgical drainage often leads to recurrence — sometimes multiple times. Embolization has been shown to significantly reduce recurrence and need for re‑drainage or re‑operation.
Faster recovery, lower morbidity: As a minimally invasive endovascular technique, MMA embolization tends to require shorter hospital stay, less pain, quicker mobilization — benefiting patients and reducing resource burden.
Paradigm shift in neurosurgical management: Adoption of endovascular/neurointerventional methods alongside — or instead of — open surgical procedures reflects modern neurosurgery’s shift toward less invasive, evidence‑based, patient‑specific treatments.

By presenting a randomized controlled trial on this topic at a major international conference, Dr. Murugavel contributes to this shift — potentially influencing future guidelines, standard-of-care, and global practice patterns.

Optimizing Visibility: Leveraging SEO & Neurosurgery Keywords

Given the relevance of your talk and the conference, a blog post like this can help increase visibility online — especially among neurosurgical professionals, trainees, and institutions. To enhance search engine reach, consider including keywords such as:

“MMA embolization cSDH”
“middle meningeal artery embolisation chronic subdural hematoma”
“MMAE versus burr‑hole drainage”
“minimally invasive neurosurgery endovascular cSDH”
“cSDH recurrence prevention”
“neurosurgery conference Dubai 2026”
“International neurosurgery CME CPD conference”
“neurointervention conference abstracts registration”

Further, linking to the conference registration page and speaker guidelines helps both for readability and authenticity.

Final Thoughts: A Great Opportunity Ahead

The upcoming 5th International Neurosurgery and Neurological Surgeons Conference offers a valuable global platform for neurosurgeons and neurointerventionists to share research, learn, and build professional networks. As a speaker, Dr. Anantha Kumar Murugavel is poised to present important data on MMA embolization for residual/recurrent chronic subdural hematoma — a topic that resonates deeply with many neurosurgeons managing cSDH worldwide.

Whether you are an early‑career surgeon, seasoned neurointerventionist, or part of a neuro‑hospital team — attending or contributing to this conference could prove highly beneficial: for knowledge, collaboration, and advancement of neurosurgical care.

Search This Blog

World Diabetes UCGConferences